INTERFERON ENHANCES TRYPTOPHAN-METABOLISM BY INDUCING PULMONARY INDOLEAMINE 2,3-DIOXYGENASE - ITS POSSIBLE OCCURRENCE IN CANCER-PATIENTS
INTERFERON ENHANCES TRYPTOPHAN-METABOLISM BY INDUCING PULMONARY INDOLEAMINE 2,3-DIOXYGENASE - ITS POSSIBLE OCCURRENCE IN CANCER-PATIENTS
复制标题
DOI:
10.1073/pnas.83.17.6622
复制
发表时间:
1986-09-01
影响因子:
11.1
通讯作者:
HAYAISHI, O
中科院分区:
文献类型:
--
作者:
YASUI, H;TAKAI, K;HAYAISHI, O
Human lungs bearing cancer (n = 27) exhibited up to an .apprxeq. 20-fold [on average .apprxeq. 5-fold (P < 0.005)] increase in the enzyme activity that degrades tryptophan to form formylkynurenine, in comparison with lungs with benign lesions (blebs) (n = 7) taken as controls. On the basis of molecular and kinetic properties, this activity was ascribed to indoleamine 2,3-dioxygenase (IDO) [indoleamine:oxygen 2,3-oxidoreductase (decyclizing)]. In vitro studies with human lung slices revealed that human interferon .gamma. (IFN-.gamma.) induced the de novo synthesis of IDO dose dependently (10-104 units/ml), and at maximum the activity reached nearly 100 times that in the control lungs described above. Human IFN-.alpha. also served as an inducer, but it was two to three orders of magnitude less potent than IFN-.gamma. relative to the antiviral titers, suggesting that IFN-.GAMMA. is the main mediator of the IDO induction. IDO thus induced in slices avidly metabolized tryptophan in situ: Upon a 24-hr incubation of lung slices pretreated with varied doses of IFN-.gamma. (10-103 units/ml), up to 96% of the typtophan in the slices was depleted and up to 70% of the tryptophan in the medium was converted, mainly to formylkynurenine, kynurenine, or both. The foregoing results suggest that an IFN-mediated induction of IDO also takes place in vivo in human lungs as a response to cancer, leading to metabolic consequences such as depletion of tryptophan and accumulation of (formyl)kynurenine, which may provide a unique host defense mechanism.